Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

Salivary anti-PGL-1 IgM may indicate active transmission of Mycobacterium leprae among young people under 16 years of age.

Macedo AC, Cunha JE Jr, Yaochite JNU, Tavares CM, Nagao-Dias AT.

Braz J Infect Dis. 2017 Sep - Oct;21(5):557-561. doi: 10.1016/j.bjid.2017.05.001. Epub 2017 Jun 9.

2.

Mitochondrial DNA Activates the NLRP3 Inflammasome and Predisposes to Type 1 Diabetes in Murine Model.

Carlos D, Costa FR, Pereira CA, Rocha FA, Yaochite JN, Oliveira GG, Carneiro FS, Tostes RC, Ramos SG, Zamboni DS, Camara NO, Ryffel B, Silva JS.

Front Immunol. 2017 Feb 27;8:164. doi: 10.3389/fimmu.2017.00164. eCollection 2017.

3.

Transcriptional profiling reveals intrinsic mRNA alterations in multipotent mesenchymal stromal cells isolated from bone marrow of newly-diagnosed type 1 diabetes patients.

de Lima KA, de Oliveira GL, Yaochite JN, Pinheiro DG, de Azevedo JT, Silva WA Jr, Covas DT, Couri CE, Simões BP, Voltarelli JC, Oliveira MC, Malmegrim KC.

Stem Cell Res Ther. 2016 Jul 12;7(1):92. doi: 10.1186/s13287-016-0351-y.

4.

Multipotent mesenchymal stromal cells from patients with newly diagnosed type 1 diabetes mellitus exhibit preserved in vitro and in vivo immunomodulatory properties.

Yaochite JN, de Lima KW, Caliari-Oliveira C, Palma PV, Couri CE, Simões BP, Covas DT, Voltarelli JC, Oliveira MC, Donadi EA, Malmegrim KC.

Stem Cell Res Ther. 2016 Jan 18;7:14. doi: 10.1186/s13287-015-0261-4.

5.

Mast cells control insulitis and increase Treg cells to confer protection against STZ-induced type 1 diabetes in mice.

Carlos D, Yaochite JN, Rocha FA, Toso VD, Malmegrim KC, Ramos SG, Jamur MC, Oliver C, Camara NO, Andrade MV, Cunha FQ, Silva JS.

Eur J Immunol. 2015 Oct;45(10):2873-85. doi: 10.1002/eji.201545498. Epub 2015 Aug 14.

6.

Intravenous administration of bone marrow-derived multipotent mesenchymal stromal cells enhances the recruitment of CD11b(+) myeloid cells to the lungs and facilitates B16-F10 melanoma colonization.

Souza LE, Almeida DC, Yaochite JN, Covas DT, Fontes AM.

Exp Cell Res. 2016 Jul 15;345(2):141-9. doi: 10.1016/j.yexcr.2015.05.021. Epub 2015 May 28.

PMID:
26027946
7.

Xenogeneic Mesenchymal Stromal Cells Improve Wound Healing and Modulate the Immune Response in an Extensive Burn Model.

Caliari-Oliveira C, Yaochite JN, Ramalho LN, Palma PV, Carlos D, Cunha Fde Q, De Souza DA, Frade MA, Covas DT, Malmegrim KC, Oliveira MC, Voltarelli JC.

Cell Transplant. 2016;25(2):201-15. doi: 10.3727/096368915X688128. Epub 2015 May 7.

PMID:
25955320
8.

Therapeutic efficacy and biodistribution of allogeneic mesenchymal stem cells delivered by intrasplenic and intrapancreatic routes in streptozotocin-induced diabetic mice.

Yaochite JN, Caliari-Oliveira C, de Souza LE, Neto LS, Palma PV, Covas DT, Malmegrim KC, Voltarelli JC, Donadi EA.

Stem Cell Res Ther. 2015 Mar 14;6:31. doi: 10.1186/s13287-015-0017-1.

9.

Dynamic changes of the Th17/Tc17 and regulatory T cell populations interfere in the experimental autoimmune diabetes pathogenesis.

Yaochite JN, Caliari-Oliveira C, Davanso MR, Carlos D, Malmegrim KC, Cardoso CR, Ramalho LN, Palma PV, da Silva JS, Cunha FQ, Covas DT, Voltarelli JC.

Immunobiology. 2013 Mar;218(3):338-52. doi: 10.1016/j.imbio.2012.05.010. Epub 2012 May 23.

PMID:
22704522

Supplemental Content

Loading ...
Support Center